Free Trial

Bolt Biotherapeutics (BOLT) Earnings Date, Estimates & Call Transcripts

Bolt Biotherapeutics logo
$0.32 0.00 (-0.92%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.31 -0.01 (-2.80%)
As of 05/23/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bolt Biotherapeutics Earnings Summary

Bolt Biotherapeutics released Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.29, which beat the consensus estimate of -$0.34 by $0.05. Quarterly revenue was reported to be $1.22 million, above analysts' expectations of $0.77 million. With a trailing EPS of -$1.67, Bolt Biotherapeutics' earnings are expected to grow next year, from ($1.61) to ($1.12) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 12)
-$0.34
Actual EPS
(May. 12)
-$0.29 Beat By $0.05
Actual Revenue
(May. 12)
$1.22M

Q1 2025 Earnings Resources

BOLT Upcoming Earnings

Bolt Biotherapeutics' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Get Bolt Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bolt Biotherapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BOLT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BOLT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bolt Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.34-$0.33-$0.34
Q2 20252-$0.32-$0.32-$0.32
Q3 20252-$0.33-$0.33-$0.33
Q4 20252-$0.34-$0.34-$0.34
FY 2025 8 -$1.33 -$1.32 -$1.33
Q1 20261-$0.34-$0.34-$0.34
Q2 20261-$0.10-$0.10-$0.10
Q3 20261-$0.10-$0.10-$0.10
Q4 20261-$0.10-$0.10-$0.10

Bolt Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/12/2025Q1 2025-$0.34-$0.29+$0.05-$0.29$0.77M$1.22M
3/24/2025Q4 2024-$0.38-$0.38--$0.42$0.79M$0.01M
11/12/2024--$0.36-$0.40 -$0.04-$0.40$1.02M$1.14M
8/13/2024Q2 2024-$0.48-$0.56 -$0.08-$0.56$1.19M$1.28M
5/14/2024Q1 2024-$0.51-$0.28+$0.23-$0.28$2.63M$5.27M
3/21/2024Q4 2023-$0.47-$0.47--$0.47$1.97M$2.09M
11/9/2023Q3 2023-$0.49-$0.43+$0.06-$0.43$1.60M$2.53M
8/7/2023Q2 2023-$0.53-$0.48+$0.05-$0.48$1.69M$1.43M

Bolt Biotherapeutics Earnings - Frequently Asked Questions

Bolt Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on BOLT's earnings history.

In the previous quarter, Bolt Biotherapeutics (NASDAQ:BOLT) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.34) by $0.05. Learn more on analysts' earnings estimate vs. BOLT's actual earnings.

Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded annual revenue of $3.64 million.

Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded net income of -$69.20 million. BOLT has generated -$1.67 earnings per share over the last four quarters.

Bolt Biotherapeutics's earnings are expected to grow from ($1.61) per share to ($1.12) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BOLT) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners